Suppr超能文献

[FT-207栓剂给药后血清、淋巴结及组织中FT-207与5-氟尿嘧啶浓度的研究]

[Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories].

作者信息

Kumazawa H, Imai N, Shioya M, Kato K, Fukaya Y, Noguchi A

出版信息

Gan To Kagaku Ryoho. 1984 Aug;11(8):1655-62.

PMID:6433799
Abstract

In 21 cancer patients receiving administration of FT-207 suppositories, we studied the concentration of FT-207 and 5-FU in the blood before surgery, and in the blood and tissues-tumor, normal and lymph node-sampled during surgery. These 21 cases were comprised of 12 cases of stomach cancer, 1 case of lymphosarcoma, 4 cases of rectal cancer, 2 cases of sigmoid cancer and 2 cases of breast cancer. Two hours after administration, the concentration of 5-FU reached its highest level and continued to maintain a level at which it could be expected to bring about clinical results even after four hours. The concentration of 5-FU in tumors and lymph nodes was high, especially in tumors compared with normal tissue (p less than 0.01). No difference could be found in the concentrations of FT-207 and 5-FU in serum and tissues from each 12 cases of stomach cancer, not only between of the early cancer and advanced cancer but also between patients more than 60 years old and those under 60 years old. No side-effects occurred in any case during suppository administration.

摘要

在21例接受FT - 207栓剂给药的癌症患者中,我们研究了手术前血液中FT - 207和5 - FU的浓度,以及手术期间采集的血液、肿瘤组织、正常组织和淋巴结中的浓度。这21例患者包括12例胃癌、1例淋巴肉瘤、4例直肠癌、2例乙状结肠癌和2例乳腺癌。给药两小时后,5 - FU浓度达到最高水平,甚至在四小时后仍持续维持在有望产生临床效果的水平。肿瘤和淋巴结中5 - FU的浓度较高,尤其是与正常组织相比,肿瘤中的浓度更高(p小于0.01)。在12例胃癌患者的血清和组织中,FT - 207和5 - FU的浓度在早期癌症和晚期癌症之间、60岁以上患者和60岁以下患者之间均未发现差异。在栓剂给药期间,任何病例均未出现副作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验